Ceradyne (CRDN) Reports Q3 EPS of $0.26; Guides FY10

October 27, 2009 6:52 AM EDT

Ceradyne (NASDAQ: CRDN) reports Q3 EPS of $0.26, versus the analyst estimate of $0.28. Revenue for the quarter was $108 million, which compares to the estimate of $109.30 million.

Guides FY10 revs to $380 - $430 million, and EPS from $0.60 - $1.05.


Related Categories

Earnings
Guidance

Stocks Mentioned

CRDN 17.04

-0.05 -0.29%
Volume: 49,610
Track CRDN


Add Your Comment